Introduction
Introduction
Introduction
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BREAKTHROUGH! 139<br />
Born in mainland China in 1952, Ho was raised in the United States<br />
and graduated from the Massachusetts Institute of Technology and Harvard<br />
Medical School. He was a medical resident at UCLA’s Cedars-Sinai<br />
Medical Center in 1981 when doctors there reported the world’s first<br />
known AIDS cases. The budding virologist immediately gravitated to<br />
the new field. In 1982, Ho accepted a postdoctoral fellowship in Martin<br />
Hirsch’s lab at Massachusetts General Hospital, where he raced to<br />
become the first to discover the virus that caused AIDS. He lost that battle,<br />
but through his daily contact with AIDS patients he gleaned crucial<br />
insights into the dynamics of the disease. In 1985 he coauthored a paper<br />
that first described the flulike symptoms that accompanied a person’s initial<br />
HIV infection. 3 But it would take the emergence of protease inhibitors<br />
nearly a decade later before he learned the deeper significance of<br />
his own observations. At the time, he, like most AIDS researchers, believed<br />
infected individuals built up antibodies to knock down the initial<br />
infection, and those antibodies kept the retrovirus in a near dormant<br />
state for years before losing their potency.<br />
He carried those beliefs with him when he moved from Boston to the<br />
new Aaron Diamond Center, which provided the young scientist with an<br />
ideal setting for pursuing intriguing avenues of research. Irene Diamond,<br />
the wife of a wealthy New York real estate developer who was devoted<br />
to medical research and the arts, believed the city that was an epicenter<br />
of the AIDS epidemic needed to do more to combat the disease. Forging<br />
a partnership with the New York City Department of Health, her foundation<br />
created the specialized center in 1988 and pledged $220 million<br />
over the next ten years for its support. The center officially opened next<br />
door to Bellevue Hospital in 1991.<br />
Often overlooked in policy debates, nonprofit institutions like the<br />
Aaron Diamond Center have long been major players in biomedical<br />
research. The Howard Hughes Medical Institute, for instance, which<br />
was endowed by the reclusive billionaire’s fortune and is located around<br />
the corner from NIH headquarters, pours more than a half billion dollars<br />
a year into basic and applied medical research. The research arm of<br />
the practice-oriented Mayo Clinic, which is headquartered in Rochester,<br />
Minnesota, spends more than $125 million a year of its own resources on<br />
applied research. Like most nonprofits, even the best endowed, the<br />
Aaron Diamond Center’s permanent staff also competes for government<br />
funds. Ho and his colleagues received major AIDS-related grants from<br />
both NIH and New York City. Coupled with the Diamond family’s generous<br />
bequest, Ho had the wherewithal to forge an independent rela-